Hector R Villarraga
Overview
Explore the profile of Hector R Villarraga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
2271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Comprehensive Assessment of the Risk of Symptomatic Embolism in Patients With Infective Endocarditis
Santos-Patarroyo S, Quintero-Martinez J, Lahr B, Chesdachai S, DeSimone D, Villarraga H, et al.
J Am Heart Assoc
. 2025 Jan;
14(3):e036648.
PMID: 39846279
Background: Echocardiographic evaluation of vegetations is crucial in infective endocarditis (IE). Although several studies have noted a link between larger vegetations and an increased risk of embolization, a more comprehensive...
2.
Wang Y, Ciampi Q, Cortigiani L, Zagatina A, Padang R, Kane G, et al.
J Am Soc Echocardiogr
. 2025 Jan;
PMID: 39818322
Background: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous entity including different phenotypes of near normal, normal, and supernormal left ventricular (LV) function. The aim of this study...
3.
Daryanani A, Abbasi M, Gomez Ardila M, Tellez-Garcia E, Garzon-Dangond J, Lin Y, et al.
Cardiooncology
. 2024 Dec;
10(1):91.
PMID: 39709512
Background: CD19 CAR T-cell therapy is a novel anti-cancer treatment that has produced remarkable responses in relapsed or refractory B-cell hematological malignancies. Cytokine Release Syndrome (CRS) is a dysregulated immune...
4.
Calle M, Abbasi M, Salah H, Scott C, Bello L, Bonikowske A, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(4):108.
PMID: 39076284
Background: To identify factors that increase the specificity of the treadmill exercise test (TMET), and develop a novel scoring system which accounts for functional capacity to aid in determining the...
5.
Hazim A, Nhola L, Kailash V, Zhang S, Sandhu N, Lerman A, et al.
Eur Heart J Open
. 2024 Jan;
4(1):oead130.
PMID: 38239934
Aims: The objective of this study was to assess the effect of HER2-directed therapy (HER2-Tx) on peripheral vasoreactivity and its correlation with cardiac function changes and the additive effects of...
6.
Abbasi M, Bruno G, Di Stefano C, Garcia Bello L, Laack N, Corbin K, et al.
J Cardiovasc Dev Dis
. 2023 Oct;
10(10).
PMID: 37887865
We sought to determine acute and subacute changes in cardiac function after proton beam (PBT) and photon beam (PhT) radiotherapy (RT) using conventional and two-dimensional speckle tracking echocardiography (2D-STE) in...
7.
Mutter R, Giri S, Fruth B, Remmes N, Boughey J, Harless C, et al.
Lancet Oncol
. 2023 Sep;
24(10):1083-1093.
PMID: 37696281
Background: Proton therapy is under investigation in breast cancer as a strategy to reduce radiation exposure to the heart and lungs. So far, studies investigating proton postmastectomy radiotherapy (PMRT) have...
8.
Kaneyuki D, Villarraga H, Gallego-Navarro C, Todd A, Pislaru S, Crestanello J, et al.
J Thorac Cardiovasc Surg
. 2023 Aug;
168(3):853-860.e2.
PMID: 37541574
Objective: Owing to a lack of supportive data, tricuspid regurgitation (TR) is usually not addressed in patients undergoing coronary artery bypass grafting (CABG). Here we evaluated changes in TR degrees...
9.
Toro-Manotas R, Santos-Patarroyo S, Villarraga H
JACC CardioOncol
. 2023 Jul;
5(3):389-391.
PMID: 37397083
No abstract available.
10.
Ng C, Bonilla H, Chang I, Aung M, Gile J, Pereira N, et al.
JACC Case Rep
. 2023 Jun;
15:101840.
PMID: 37283829
Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the management of aggressive hematologic malignancies. However, its role in patients with lymphoma and cardiac metastasis or cardiomyopathy remains undefined due to...